Quantcast

Latest Oxygen Biotherapeutics Inc. Stories

2014-05-12 08:27:09

NEW YORK, May 12, 2014 /PRNewswire/ -- Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) Today, approximately 8% of the world's population is over the age of 65; and that number is expected to double in less than 40 years. As the world's population ages in the coming years, the demand for critical care services will undoubtedly increase in both developed and underdeveloped countries across the world. In fact, GBI Research estimates that the size of this market will grow from $2.3 billion in...

2014-04-21 08:25:06

NEW YORK, April 21, 2014 /PRNewswire/ -- Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), an emerging competitor, is engaged in the business of developing biotechnology products in the nature of blood substitutes with a focus on oxygen delivery to tissue. It is currently developing Oxycyte(TM), a product which is a safe and effective oxygen carrier for use in surgical and similar medical situations. The Company's Oxycyte oxygen carrier product is a perfluorocarbon emulsified with water...

2010-12-03 11:34:00

DURHAM, N.C., Dec. 3, 2010 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) (SIX Swiss Exchange: OXBT) today announced that the Company plans to report second quarter fiscal year 2011 financial results on Thursday, December 9, 2010. Oxygen's Chairman and CEO Chris Stern, and Chief Financial Officer Michael Jebsen, will host a conference call and live webcast to discuss the results on Friday, December 10, 2010 at 11 a.m. EST. To access the live teleconference dial...

2010-01-21 08:00:00

DURHAM, N.C., Jan. 21 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) chairman and CEO Chris Stern will preside over the NASDAQ Opening Bell on Friday, January 22, 2010. A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx starting at 9:20 a.m. eastern time. About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in...

2010-01-13 13:59:00

DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that the company's common stock will begin trading on the NASDAQ Capital Market with the opening of trading on Friday, January 15, 2010. The shares will continue to trade under the symbol OXBT. In addition, company chairman and CEO Chris Stern will be in New York to ring the opening bell at the NASDAQ one week later on Friday, January 22. About Oxygen Biotherapeutics,...

2010-01-13 12:23:00

DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) chairman and CEO Chris Stern outlined plans for the introduction of new products during a presentation today at the OneMedForum 2010 investor conference in San Francisco. During the brief presentation, limited by conference organizers to 10 minutes per company, Stern said Oxygen Biotherapeutics, Inc. plans to launch four products in its cosmetics line during 2010. They include an eye...

2010-01-11 07:30:00

DURHAM, N.C., Jan. 11 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that company chairman and CEO Chris Stern will present at the OneMedForum 2010 investor conference in San Francisco on Wednesday, Jan. 13, 2010. The presentation, limited by conference organizers to 10 minutes per company, will be at 9:00 a.m. pacific time and will be webcast live. A link to the webcast will be available the day of the presentation at the following url:...

2010-01-08 14:23:00

DURHAM, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that its common stock has been approved for listing on the NASDAQ Capital Market. "Moving up from the OTC Bulletin Board to the NASDAQ is a very important milestone for our company," said company chairman and CEO Chris J. Stern. "Being listed on the NASDAQ provides us with greater visibility for our company, more liquidity for our stock and the opportunity to further...

2009-12-14 07:30:00

DURHAM, N.C., Dec. 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced the expansion of the company's board of directors with the addition of Lt. Gen. Ronald R. Blanck, DO, U.S. Army (Ret.). Dr. Blanck is chairman of Martin, Blanck & Associates, a federal health services consulting firm based in Falls Church, Virginia. With his addition, the company board now has nine members. Dr. Blanck began his military career in 1968 as a medical...

2009-12-04 10:08:00

DURHAM, N.C., Dec. 4 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier. "This trial is of invaluable importance in improving the outcome of patients with severe TBI. We hope to finally prove...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'